Promoting Trade Generics

On A Mission to Make A Healthier India!

India is the largest provider of generics worldwide, supplying over 50% of Africa’s requirement for generics, 40% of generic demand in the US, and 25% of all medicine in the UK.

In the Indian pharmaceutical supply chain, Stockists rely extensively on CNFs or super stockists for the procurement and distribution of pharmaceutical products.

Issues

Limited Autonomy

Stockists face a reduced ability to manage their inventory and operations independently, relying heavily on the decisions and capabilities of the CNFs or super stockists.

Supply Disruptions

Any disruptions or delays from CNFs or super stockists can directly impact the stockist’s ability to fulfill orders promptly, leading to shortages in pharmacies and healthcare facilities.

Increased Costs

The indirect route through CNFs or super stockists may inflate costs due to additional margins, affecting the overall affordability of medications for end consumers.

Challenges Faced by Manufacturers

• Concentration of sales from only the most competitive product lines
• Cannot achieve cost leadership across all product lines
• Comparison of prices with other manufacturers leads to continuous price erosion

Challenges Faced by Pharmacies

• The rising threat of e-pharmacies to brick-and-mortar pharmacies
• Price competition in the market - Cannot offer additional discounts to customers
• Price disparity between different parts of the country on the same goods

Challenges Faced by Consumers

• Increasing costs of healthcare
• Lack of awareness of quality standards
• Online pharmacies are cheaper, but the delivery period is too long - Cannot predict medical exigencies

Venus Collabs With DAVAI - A One-Stop Solution for Pharma Needs

In an attempt to overcome these issues and make healthcare more and more accessible, Venus partnered with DAVAI.

About DAVAI

An AI-backed B2B e-commerce platform that connects pharmaceutical manufacturers directly with retailers. DAVAI is a pioneering B2B marketplace that’s reshaping the pharmaceutical supply chain landscape in our country.

Vision

To digitize the procurement pathway in the pharmaceutical industry, our platform facilitates direct transactions from pharmaceutical companies to stockists and wholesalers, eliminating unnecessary intermediaries and streamlining the supply chain process.

Field of Innovation

Technology InnovationThe use of a technologically powered platform eliminates the need for any intermediaries, enabling quick and direct access to pharmaceutical products.

Business Model InnovationIt’s a novel business model presented to the pharma industry – the first-of-its-kind creation of a tech-savvy, convenient, straightforward, and advanced ecosystem for the concerned stakeholders.

The Impact Venus - DAVAI Collab Creates!

Market Need

Effectively addresses critical pain points, such as reducing dependency on intermediaries, streamlining procurement, and improving transparency.

Industry Adoption

The willingness and positive approach of stockists and distributors towards active adoption of DAVAI's model drive substantial change within the industry.

Innovative Approach

DAVAI's direct-to-manufacturer procurement model revolutionizes the existing norms, significantly altering established practices and resulting in a disruption in the existing market.

Social Impact

By facilitating direct transactions from the company to stockists and wholesalers, the partnership is contributing significantly to Sustainable Development Goal 9 (SDG 9).

Optimized Logistics

Ensures swift deliveries with fulfillment centers in 7 locations across India. 70% of deliveries are fulfilled within 72 hours, minimizing delays.

Universal Health Coverage

Supports GoI's Jan Aushadi Pariyojana, providing quality generic medicines at affordable prices. Aligned with the vision to reduce healthcare budgets for every Indian citizen.

DAVAI Website - https://dav-ai.com/